MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning

High-throughput screening (HTS), as one of the key techniques in drug discovery, is frequently used to identify promising drug candidates in a largely automated and cost-effective way. One of the necessary conditions for successful HTS campaigns is a large and diverse compound library, enabling hund...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chemical information and modeling 2023-05, Vol.63 (9), p.2667-2678
Hauptverfasser: Buterez, David, Janet, Jon Paul, Kiddle, Steven J., Liò, Pietro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2678
container_issue 9
container_start_page 2667
container_title Journal of chemical information and modeling
container_volume 63
creator Buterez, David
Janet, Jon Paul
Kiddle, Steven J.
Liò, Pietro
description High-throughput screening (HTS), as one of the key techniques in drug discovery, is frequently used to identify promising drug candidates in a largely automated and cost-effective way. One of the necessary conditions for successful HTS campaigns is a large and diverse compound library, enabling hundreds of thousands of activity measurements per project. Such collections of data hold great promise for computational and experimental drug discovery efforts, especially when leveraged in combination with modern deep learning techniques, and can potentially lead to improved drug activity predictions and cheaper and more effective experimental design. However, existing collections of machine-learning-ready public datasets do not exploit the multiple data modalities present in real-world HTS projects. Thus, the largest fraction of experimental measurements, corresponding to hundreds of thousands of “noisy” activity values from primary screening, are effectively ignored in the majority of machine learning models of HTS data. To address these limitations, we introduce Multifidelity PubChem BioAssay (MF-PCBA), a curated collection of 60 datasets that includes two data modalities for each dataset, corresponding to primary and confirmatory screening, an aspect that we call multifidelity. Multifidelity data accurately reflect real-world HTS conventions and present a new, challenging task for machine learning: the integration of low- and high-fidelity measurements through molecular representation learning, taking into account the orders-of-magnitude difference in size between the primary and confirmatory screens. Here we detail the steps taken to assemble MF-PCBA in terms of data acquisition from PubChem and the filtering steps required to curate the raw data. We also provide an evaluation of a recent deep-learning-based method for multifidelity integration across the introduced datasets, demonstrating the benefit of leveraging all HTS modalities, and a discussion in terms of the roughness of the molecular activity landscape. In total, MF-PCBA contains over 16.6 million unique molecule–protein interactions. The datasets can be easily assembled by using the source code available at https://github.com/davidbuterez/mf-pcba.
doi_str_mv 10.1021/acs.jcim.2c01569
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10170507</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2801978909</sourcerecordid><originalsourceid>FETCH-LOGICAL-a462t-528e0037d3cc716dc2f95cde3809f71dc5e7cae332b544dc66088bc6f40be88e3</originalsourceid><addsrcrecordid>eNp1kc1vEzEQxS0EoqXlzglZ4sKBDfZ6P2wuVZu2FClRK1EkbpYzO7vrsPEGe7dS_vs6JKkAqSdb8u89v5lHyDvOJpyl_LOBMFmCXU1SYDwv1AtyzPNMJapgP18e7rkqjsibEJaMCaGK9DU5EiXLZS7lMYH5dXI3vTj_QudjN9jaVtjZYUNvbNMm963vx6ZdjwP9Dh7RWdfQC3TQroz_FWjde3rpx4Ze2gD9A_oNNa6icwOtdUhnaPxWckpe1aYL-HZ_npAf11f305tkdvv12_R8lpisSIckTyXGiGUlAEpeVJDWKocKhWSqLnkFOZZgUIh0kWdZBUXBpFxAUWdsgVKiOCFnO9_1uFhhBegGbzq99jbG3ejeWP3vi7OtbvoHzRmPC2FldPi4d_D97xHDoFdxMuw647Afg04l46qUiqmIfvgPXfajd3G-SHGelhkTPFJsR4HvQ_BYP6XhTG8r1LFCva1Q7yuMkvd_T_EkOHQWgU874I_08Omzfo_l86i9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2811274031</pqid></control><display><type>article</type><title>MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning</title><source>MEDLINE</source><source>American Chemical Society Publications</source><creator>Buterez, David ; Janet, Jon Paul ; Kiddle, Steven J. ; Liò, Pietro</creator><creatorcontrib>Buterez, David ; Janet, Jon Paul ; Kiddle, Steven J. ; Liò, Pietro</creatorcontrib><description>High-throughput screening (HTS), as one of the key techniques in drug discovery, is frequently used to identify promising drug candidates in a largely automated and cost-effective way. One of the necessary conditions for successful HTS campaigns is a large and diverse compound library, enabling hundreds of thousands of activity measurements per project. Such collections of data hold great promise for computational and experimental drug discovery efforts, especially when leveraged in combination with modern deep learning techniques, and can potentially lead to improved drug activity predictions and cheaper and more effective experimental design. However, existing collections of machine-learning-ready public datasets do not exploit the multiple data modalities present in real-world HTS projects. Thus, the largest fraction of experimental measurements, corresponding to hundreds of thousands of “noisy” activity values from primary screening, are effectively ignored in the majority of machine learning models of HTS data. To address these limitations, we introduce Multifidelity PubChem BioAssay (MF-PCBA), a curated collection of 60 datasets that includes two data modalities for each dataset, corresponding to primary and confirmatory screening, an aspect that we call multifidelity. Multifidelity data accurately reflect real-world HTS conventions and present a new, challenging task for machine learning: the integration of low- and high-fidelity measurements through molecular representation learning, taking into account the orders-of-magnitude difference in size between the primary and confirmatory screens. Here we detail the steps taken to assemble MF-PCBA in terms of data acquisition from PubChem and the filtering steps required to curate the raw data. We also provide an evaluation of a recent deep-learning-based method for multifidelity integration across the introduced datasets, demonstrating the benefit of leveraging all HTS modalities, and a discussion in terms of the roughness of the molecular activity landscape. In total, MF-PCBA contains over 16.6 million unique molecule–protein interactions. The datasets can be easily assembled by using the source code available at https://github.com/davidbuterez/mf-pcba.</description><identifier>ISSN: 1549-9596</identifier><identifier>EISSN: 1549-960X</identifier><identifier>DOI: 10.1021/acs.jcim.2c01569</identifier><identifier>PMID: 37058588</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Benchmarking ; Biological Assay ; Data acquisition ; Datasets ; Deep learning ; Design of experiments ; Drug Discovery - methods ; High-Throughput Screening Assays - methods ; Machine Learning ; Machine Learning and Deep Learning ; Screening ; Source code</subject><ispartof>Journal of chemical information and modeling, 2023-05, Vol.63 (9), p.2667-2678</ispartof><rights>2023 The Authors. Published by American Chemical Society</rights><rights>Copyright American Chemical Society May 8, 2023</rights><rights>2023 The Authors. Published by American Chemical Society 2023 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a462t-528e0037d3cc716dc2f95cde3809f71dc5e7cae332b544dc66088bc6f40be88e3</citedby><cites>FETCH-LOGICAL-a462t-528e0037d3cc716dc2f95cde3809f71dc5e7cae332b544dc66088bc6f40be88e3</cites><orcidid>0000-0001-6558-0833 ; 0000-0001-7825-4797</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jcim.2c01569$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jcim.2c01569$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,780,784,885,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37058588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buterez, David</creatorcontrib><creatorcontrib>Janet, Jon Paul</creatorcontrib><creatorcontrib>Kiddle, Steven J.</creatorcontrib><creatorcontrib>Liò, Pietro</creatorcontrib><title>MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning</title><title>Journal of chemical information and modeling</title><addtitle>J. Chem. Inf. Model</addtitle><description>High-throughput screening (HTS), as one of the key techniques in drug discovery, is frequently used to identify promising drug candidates in a largely automated and cost-effective way. One of the necessary conditions for successful HTS campaigns is a large and diverse compound library, enabling hundreds of thousands of activity measurements per project. Such collections of data hold great promise for computational and experimental drug discovery efforts, especially when leveraged in combination with modern deep learning techniques, and can potentially lead to improved drug activity predictions and cheaper and more effective experimental design. However, existing collections of machine-learning-ready public datasets do not exploit the multiple data modalities present in real-world HTS projects. Thus, the largest fraction of experimental measurements, corresponding to hundreds of thousands of “noisy” activity values from primary screening, are effectively ignored in the majority of machine learning models of HTS data. To address these limitations, we introduce Multifidelity PubChem BioAssay (MF-PCBA), a curated collection of 60 datasets that includes two data modalities for each dataset, corresponding to primary and confirmatory screening, an aspect that we call multifidelity. Multifidelity data accurately reflect real-world HTS conventions and present a new, challenging task for machine learning: the integration of low- and high-fidelity measurements through molecular representation learning, taking into account the orders-of-magnitude difference in size between the primary and confirmatory screens. Here we detail the steps taken to assemble MF-PCBA in terms of data acquisition from PubChem and the filtering steps required to curate the raw data. We also provide an evaluation of a recent deep-learning-based method for multifidelity integration across the introduced datasets, demonstrating the benefit of leveraging all HTS modalities, and a discussion in terms of the roughness of the molecular activity landscape. In total, MF-PCBA contains over 16.6 million unique molecule–protein interactions. The datasets can be easily assembled by using the source code available at https://github.com/davidbuterez/mf-pcba.</description><subject>Benchmarking</subject><subject>Biological Assay</subject><subject>Data acquisition</subject><subject>Datasets</subject><subject>Deep learning</subject><subject>Design of experiments</subject><subject>Drug Discovery - methods</subject><subject>High-Throughput Screening Assays - methods</subject><subject>Machine Learning</subject><subject>Machine Learning and Deep Learning</subject><subject>Screening</subject><subject>Source code</subject><issn>1549-9596</issn><issn>1549-960X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1vEzEQxS0EoqXlzglZ4sKBDfZ6P2wuVZu2FClRK1EkbpYzO7vrsPEGe7dS_vs6JKkAqSdb8u89v5lHyDvOJpyl_LOBMFmCXU1SYDwv1AtyzPNMJapgP18e7rkqjsibEJaMCaGK9DU5EiXLZS7lMYH5dXI3vTj_QudjN9jaVtjZYUNvbNMm963vx6ZdjwP9Dh7RWdfQC3TQroz_FWjde3rpx4Ze2gD9A_oNNa6icwOtdUhnaPxWckpe1aYL-HZ_npAf11f305tkdvv12_R8lpisSIckTyXGiGUlAEpeVJDWKocKhWSqLnkFOZZgUIh0kWdZBUXBpFxAUWdsgVKiOCFnO9_1uFhhBegGbzq99jbG3ejeWP3vi7OtbvoHzRmPC2FldPi4d_D97xHDoFdxMuw647Afg04l46qUiqmIfvgPXfajd3G-SHGelhkTPFJsR4HvQ_BYP6XhTG8r1LFCva1Q7yuMkvd_T_EkOHQWgU874I_08Omzfo_l86i9</recordid><startdate>20230508</startdate><enddate>20230508</enddate><creator>Buterez, David</creator><creator>Janet, Jon Paul</creator><creator>Kiddle, Steven J.</creator><creator>Liò, Pietro</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SC</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>JQ2</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6558-0833</orcidid><orcidid>https://orcid.org/0000-0001-7825-4797</orcidid></search><sort><creationdate>20230508</creationdate><title>MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning</title><author>Buterez, David ; Janet, Jon Paul ; Kiddle, Steven J. ; Liò, Pietro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a462t-528e0037d3cc716dc2f95cde3809f71dc5e7cae332b544dc66088bc6f40be88e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Benchmarking</topic><topic>Biological Assay</topic><topic>Data acquisition</topic><topic>Datasets</topic><topic>Deep learning</topic><topic>Design of experiments</topic><topic>Drug Discovery - methods</topic><topic>High-Throughput Screening Assays - methods</topic><topic>Machine Learning</topic><topic>Machine Learning and Deep Learning</topic><topic>Screening</topic><topic>Source code</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buterez, David</creatorcontrib><creatorcontrib>Janet, Jon Paul</creatorcontrib><creatorcontrib>Kiddle, Steven J.</creatorcontrib><creatorcontrib>Liò, Pietro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Computer and Information Systems Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of chemical information and modeling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buterez, David</au><au>Janet, Jon Paul</au><au>Kiddle, Steven J.</au><au>Liò, Pietro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning</atitle><jtitle>Journal of chemical information and modeling</jtitle><addtitle>J. Chem. Inf. Model</addtitle><date>2023-05-08</date><risdate>2023</risdate><volume>63</volume><issue>9</issue><spage>2667</spage><epage>2678</epage><pages>2667-2678</pages><issn>1549-9596</issn><eissn>1549-960X</eissn><abstract>High-throughput screening (HTS), as one of the key techniques in drug discovery, is frequently used to identify promising drug candidates in a largely automated and cost-effective way. One of the necessary conditions for successful HTS campaigns is a large and diverse compound library, enabling hundreds of thousands of activity measurements per project. Such collections of data hold great promise for computational and experimental drug discovery efforts, especially when leveraged in combination with modern deep learning techniques, and can potentially lead to improved drug activity predictions and cheaper and more effective experimental design. However, existing collections of machine-learning-ready public datasets do not exploit the multiple data modalities present in real-world HTS projects. Thus, the largest fraction of experimental measurements, corresponding to hundreds of thousands of “noisy” activity values from primary screening, are effectively ignored in the majority of machine learning models of HTS data. To address these limitations, we introduce Multifidelity PubChem BioAssay (MF-PCBA), a curated collection of 60 datasets that includes two data modalities for each dataset, corresponding to primary and confirmatory screening, an aspect that we call multifidelity. Multifidelity data accurately reflect real-world HTS conventions and present a new, challenging task for machine learning: the integration of low- and high-fidelity measurements through molecular representation learning, taking into account the orders-of-magnitude difference in size between the primary and confirmatory screens. Here we detail the steps taken to assemble MF-PCBA in terms of data acquisition from PubChem and the filtering steps required to curate the raw data. We also provide an evaluation of a recent deep-learning-based method for multifidelity integration across the introduced datasets, demonstrating the benefit of leveraging all HTS modalities, and a discussion in terms of the roughness of the molecular activity landscape. In total, MF-PCBA contains over 16.6 million unique molecule–protein interactions. The datasets can be easily assembled by using the source code available at https://github.com/davidbuterez/mf-pcba.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>37058588</pmid><doi>10.1021/acs.jcim.2c01569</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-6558-0833</orcidid><orcidid>https://orcid.org/0000-0001-7825-4797</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1549-9596
ispartof Journal of chemical information and modeling, 2023-05, Vol.63 (9), p.2667-2678
issn 1549-9596
1549-960X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10170507
source MEDLINE; American Chemical Society Publications
subjects Benchmarking
Biological Assay
Data acquisition
Datasets
Deep learning
Design of experiments
Drug Discovery - methods
High-Throughput Screening Assays - methods
Machine Learning
Machine Learning and Deep Learning
Screening
Source code
title MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A16%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MF-PCBA:%20Multifidelity%20High-Throughput%20Screening%20Benchmarks%20for%20Drug%20Discovery%20and%20Machine%20Learning&rft.jtitle=Journal%20of%20chemical%20information%20and%20modeling&rft.au=Buterez,%20David&rft.date=2023-05-08&rft.volume=63&rft.issue=9&rft.spage=2667&rft.epage=2678&rft.pages=2667-2678&rft.issn=1549-9596&rft.eissn=1549-960X&rft_id=info:doi/10.1021/acs.jcim.2c01569&rft_dat=%3Cproquest_pubme%3E2801978909%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2811274031&rft_id=info:pmid/37058588&rfr_iscdi=true